Literature DB >> 8079741

Intratumoral pO2 histography as predictive assay in advanced cancer of the uterine cervix.

M Höckel1, C Knoop, K Schlenger, B Vorndran, P G Knapstein, P Vaupel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8079741     DOI： 10.1007/978-1-4615-2468-7_59

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  17 in total

1.  Modeling of oxygen transport across tumor multicellular layers.

Authors:  Rod D Braun; Alexis L Beatty
Journal:  Microvasc Res       Date:  2006-12-27       Impact factor: 3.514

2.  Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.

Authors:  S H Yeh; R S Liu; L C Wu; D J Yang; S H Yen; C W Chang; T W Yu; K L Chou; K Y Chen
Journal:  Eur J Nucl Med       Date:  1996-10

3.  Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

Authors:  Keiichi Jingu; Hisanori Ariga; Tomohiro Kaneta; Yoshihiro Takai; Ken Takeda; Lindel Katja; Kakutaro Narazaki; Takahiro Metoki; Keisuke Fujimoto; Rei Umezawa; Yoshihiro Ogawa; Kenji Nemoto; Masashi Koto; Masatoshi Mitsuya; Naruhiro Matsufuji; Shoki Takahashi; Shogo Yamada
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

Review 4.  Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?

Authors:  Jianbo Li; Guojian Zhang; Xuemei Wang; Xiao-Feng Li
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

Review 5.  Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Authors:  J P Holland; J S Lewis; F Dehdashti
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

6.  (18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings.

Authors:  Tao Huang; A Cahid Civelek; Huaiyu Zheng; Chin K Ng; Xiaoxian Duan; Junling Li; Gregory C Postel; Baozhong Shen; Xiao-Feng Li
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08

7.  Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.

Authors:  Kelin Wang; Ellen Yorke; Sadek A Nehmeh; John L Humm; C Clifton Ling
Journal:  Med Phys       Date:  2009-10       Impact factor: 4.071

8.  A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.

Authors:  Bixiu Wen; Paul Burgman; Pat Zanzonico; Joseph O'donoghue; Shangde Cai; Ron Finn; Inna Serganova; Ronald Blasberg; Juri Gelovani; Gloria C Li; C Clifton Ling
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-16       Impact factor: 9.236

9.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

10.  In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.

Authors:  Paul D Bonnitcha; Amy L Vāvere; Jason S Lewis; Jonathan R Dilworth
Journal:  J Med Chem       Date:  2008-04-17       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.